423 related articles for article (PubMed ID: 11219485)
1. Anticancer drug-induced kidney disorders.
Kintzel PE
Drug Saf; 2001 Jan; 24(1):19-38. PubMed ID: 11219485
[TBL] [Abstract][Full Text] [Related]
2. [Prevention and management of nephrotoxicity from anti-cancer agents].
Miyazaki J; Kawai K
Nihon Rinsho; 2003 Jun; 61(6):973-7. PubMed ID: 12806945
[TBL] [Abstract][Full Text] [Related]
3. Prevention of Chemotherapy-Induced Nephrotoxicity in Children with Cancer.
Sharbaf FG; Farhangi H; Assadi F
Int J Prev Med; 2017; 8():76. PubMed ID: 29114374
[TBL] [Abstract][Full Text] [Related]
4. Children's toxicology from bench to bed--Drug-induced renal injury (2): Nephrotoxicity induced by cisplatin and ifosfamide in children.
Fujieda M; Matsunaga A; Hayashi A; Tauchi H; Chayama K; Sekine T
J Toxicol Sci; 2009; 34 Suppl 2():SP251-7. PubMed ID: 19571477
[TBL] [Abstract][Full Text] [Related]
5. A prospective evaluation of ifosfamide-related nephrotoxicity in children and young adults.
Ho PT; Zimmerman K; Wexler LH; Blaney S; Jarosinski P; Weaver-McClure L; Izraeli S; Balis FM
Cancer; 1995 Dec; 76(12):2557-64. PubMed ID: 8625085
[TBL] [Abstract][Full Text] [Related]
6. Nephrotoxicity induced by cancer chemotherapy with special emphasis on cisplatin toxicity.
Ries F; Klastersky J
Am J Kidney Dis; 1986 Nov; 8(5):368-79. PubMed ID: 3538860
[TBL] [Abstract][Full Text] [Related]
7. Early and late renal adverse effects after potentially nephrotoxic treatment for childhood cancer.
Knijnenburg SL; Mulder RL; Schouten-Van Meeteren AY; Bökenkamp A; Blufpand H; van Dulmen-den Broeder E; Veening MA; Kremer LC; Jaspers MW
Cochrane Database Syst Rev; 2013 Oct; (10):CD008944. PubMed ID: 24101439
[TBL] [Abstract][Full Text] [Related]
8. [Nephrotoxicity of ifosfamide with special reference to Fanconi Syndrome].
Rogowska E; Woźniak W
Med Wieku Rozwoj; 2004; 8(2 Pt 1):289-95. PubMed ID: 15738605
[TBL] [Abstract][Full Text] [Related]
9. [The kidney in children under chemotherapy].
Cachat F; Guignard JP
Rev Med Suisse Romande; 1996 Dec; 116(12):985-93. PubMed ID: 9026889
[TBL] [Abstract][Full Text] [Related]
10. Management of acute renal failure in the elderly. Treatment options.
Mandal AK; Baig M; Koutoubi Z
Drugs Aging; 1996 Oct; 9(4):226-50. PubMed ID: 8894522
[TBL] [Abstract][Full Text] [Related]
11. Management of acute renal failure in the elderly patient: a clinician's guide.
Cheung CM; Ponnusamy A; Anderton JG
Drugs Aging; 2008; 25(6):455-76. PubMed ID: 18540687
[TBL] [Abstract][Full Text] [Related]
12. Prospective evaluation of high-dose ifosfamide-related nephrotoxicity in young adult patients with recurrent osteosarcoma previously treated with cisplatin, methotrexate and standard-dose ifosfamide.
Ferrari S; Zolezzi C; Cesari M; Fasano MC; Lamanna G; Bacci G
Anticancer Drugs; 1999 Jan; 10(1):25-31. PubMed ID: 10194544
[TBL] [Abstract][Full Text] [Related]
13. Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention.
Pai VB; Nahata MC
Drug Saf; 2000 Apr; 22(4):263-302. PubMed ID: 10789823
[TBL] [Abstract][Full Text] [Related]
14. [Nephrotoxicity of cytostatic drugs. Pathogenesis, prevention, therapy].
Tesar V; Tesarová P; Klener P
Cas Lek Cesk; 1997 Apr; 136(7):205-9. PubMed ID: 9221195
[TBL] [Abstract][Full Text] [Related]
15. Chronic ifosfamide nephrotoxicity in children.
Skinner R
Med Pediatr Oncol; 2003 Sep; 41(3):190-7. PubMed ID: 12868118
[TBL] [Abstract][Full Text] [Related]
16. Comparative study of the acute nephrotoxicity from standard dose cisplatin +/- ifosfamide and high-dose chemotherapy with carboplatin and ifosfamide.
Hartmann JT; Fels LM; Franzke A; Knop S; Renn M; Maess B; Panagiotou P; Lampe H; Kanz L; Stolte H; Bokemeyer C
Anticancer Res; 2000; 20(5C):3767-73. PubMed ID: 11268452
[TBL] [Abstract][Full Text] [Related]
17. The utility of (99m)Tc-DMSA and Tc(99m)-EC scintigraphy for early diagnosis of ifosfamide induced nephrotoxicity.
Caglar M; Yarís N; Akyuz C
Nucl Med Commun; 2001 Dec; 22(12):1325-32. PubMed ID: 11711903
[TBL] [Abstract][Full Text] [Related]
18. Nephrotoxicity of anticancer drugs--an underestimated problem?
Lameire N; Kruse V; Rottey S
Acta Clin Belg; 2011; 66(5):337-45. PubMed ID: 22145268
[TBL] [Abstract][Full Text] [Related]
19. Renal function in high dose chemotherapy and autologous hematopoietic cell support treatment for breast cancer.
Merouani A; Shpall EJ; Jones RB; Archer PG; Schrier RW
Kidney Int; 1996 Sep; 50(3):1026-31. PubMed ID: 8872980
[TBL] [Abstract][Full Text] [Related]
20. [Nephrotoxicity of antineoplastic drugs].
Suzuki T; Nosaka K
Ryoikibetsu Shokogun Shirizu; 1997; (16 Pt 1):542-6. PubMed ID: 9277811
[No Abstract] [Full Text] [Related]
[Next] [New Search]
